Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma-Reference-Cited by-同舟云学术

Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma

Published:2018-12 Issue:12 Volume:41 Page:1204-1210
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Larbcharoensub Noppadol,Mahaprom Komkrit,Jiarpinitnun Chuleeporn,Trachu Narumol,Tubthong Nattha,Pattaranutaporn Poompis,Sirachainan Ekaphop,Ngamphaiboon Nuttapong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference30 articles.

1. Cancer in Asia—incidence rates based on data in cancer incidence in five continents IX (1998-2002);Shin;Asian Pac J Cancer Prev,2011

2. Epstein-Barr virus and cancer;Thompson;Clin Cancer Res,2004

3. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival;Lin;J Clin Oncol,2003

4. Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type;Foo;Ann Oncol,2002

5. Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer;Chua;Jpn J Clin Oncol,2008

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nomogram based on circulating CD8+ T cell and platelet-to-lymphocyte ratio to predict overall survival of patients with locally advanced nasopharyngeal carcinoma;Radiation Oncology;2024-08-13

2. A nomogram based on circulating CD8 + T cell and platelet-to-lymphocyte ratio to predict overall survival of patients with locally advanced nasopharyngeal carcinoma;2024-05-21

3. Combination strategy exploration for prior treated recurrent or metastatic nasopharyngeal carcinoma in the era of immunotherapy;Scientific Reports;2024-01-20

4. Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma;BMC Cancer;2023-12-21

5. Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma;Microorganisms;2023-12-20